International Medical Director, Hematology

International Medical Director, Hematology

The International  Medical Director (IMD), reporting to the Group International Medical Director (GIMD) for the Myeloid-Benign Global Medical Team, is a core role to support the joint planning and execution of the Medical and Evidence Generation Strategy for the assigned product(s) / Indication(s) based on key insights and perspectives from multiple stakeholders.

The role requires an outstanding track record of previous experience in Medical Affairs, preferably with Hematology-Hemophilia expertise.

Main responsibilities:

Medical Strategy

• Accountable for the evidence generation strategy planning and execution, incl. (but not limited to) identifying medical and access gaps and needs as part of the overall medical strategy
• Responsible for the joint planning and execution of the Medical Strategy for the assigned product(s) / Indication(s)

Evidence Generation Strategy Planning and Execution

• Drives and leads the strategy of the integrated evidence generation activities, incl. Roche sponsored clinical studies, Investigator Initiated Studies (IIS), RWD
• Accountable for evidence generation activities for the assigned product (s) / Indication(s), including risk benefit assessment and medical monitoring in all medical affairs interventional studies
• Takes the role of Lead Scientific Responsible and acts as a member of the Study Management Team (SMT)  
• Assesses the needs and coordinates compassionate use of the assigned product(s)

Patient Access

• In collaboration with Global Access (GA) and appropriate Affiliates stakeholders, identifies the evidence generation needs/gaps in order to obtain and maintain patient access and integrates them into the evidence generation strategy
• Provides medical expertise and input into the market access, brand and lifecycle strategies and plans (e.g. Life Cycle Plans, Brand Plans, Launch Plans,  Comparative Benefit Risk Assessments and other relevant documents)

External Collaborations

• Develops, advances and maintains TAE interactions and collaborations, incl. those aimed to set up and conduct evidence generation activities
• Represents Roche in peer-to-peer interactions with external collaboration partners, including in patient-company interactions

We are looking for a MD with relevant clinical experience (patient care decision-making) at the point of care. Specialization degree and experience in the disease area are a plus. With relevant pharmaceutical industry experience in Medical Affairs function (preferably at Global or Regional level)​. You will bring:

• Experience in Evidence Generation within or outside the pharmaceutical industry, including protocol-writing.
• Experience in Compassionate Use Program/Compassionate Use Request management
• Understanding of business context, access and regulatory environments and trends
• Experienced educator/ presenter.
• Experience of partnership with therapeutic area experts and external organizations is strongly preferred
• Previous experience with launch of drugs/indications is preferred
• Clinical or scientific experience in the field of Hematology-Hemophilia is a plus.
• Fluency in written and spoken English

Functional competencies, including but not limited to, organization, prioritization and planning skills, negotiation skills, communication & presentation skills

Roche is an equal opportunity employer.